Article

Unveiling the Burden of MASLD and Liver Fibrosis in India: Novel Insights from the Phenome India Study into fibrosis without MASLD

2025-10-13

Abstract excerpt

<h4>Background</h4> Metabolically–dysfunction–associated steatotic liver disease (MASLD) is rising globally, including in India, yet community-based data remain scarce. We addressed this critical knowledge gap by assessing the prevalence, distribution, and characteristics of MASLD subgroups and fibrosis, leveraging the Phenome India–CSIR Health Cohort Knowledgebase (PI-CHeCK) study. <h4>Methods</h4> In this pros...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a853f03c-9881-5bb2-9d24-722ba13236b9
DOI: 10.1101/2025.10.11.25337761

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Unveiling the Burden of MASLD and Liver Fibrosis in India: Novel Insights from the Phenome India Study into fibrosis without MASLDDOI 10.1101/2025.10.11.25337761Read

Current Insights into Liver Fibrosis: Epidemiological Patterns, Etiopathogenesis, Clinical Correlates, and Research AgendaSemantic proximity Read

Prevalence of Significant and Advanced Hepatic Fibrosis in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)Semantic proximity Read

Epidemiology, temporal trends, and fibrosis risk stratification in metabolic dysfunction-associated steatotic liver disease in UK primary care: a population-based cohort and nested case-control studySemantic proximity Read

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.Semantic proximity Read

Cardiometabolic phenotype linked to fibrosis and mortality in metabolic dysfunction-associated steatotic liver disease.Semantic proximity Read

Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated alcohol‑related liver disease represent distinct clinical phenotypes and fibrosis risks: insights from a population-based Polish cohort.Semantic proximity Read

Molecular characterization of liver steatosis through circulating proteins, metabolites and lipidsSemantic proximity Read

Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and BeyondSemantic proximity Read

Steatosis Non-Invasive Tests Accurately Predict Metabolic Dysfunction-Associated Steatotic Liver Disease, While Fibrosis Non-Invasive Tests Fall Short: Validation in U.S. Adult PopulationSemantic proximity Read

Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtypingSemantic proximity Read

An Invisible Early Steatosis Phenotype Defined for a Large Population-Based CohortSemantic proximity Read

Genetic susceptibility versus fibrosis progression in North Indian MASLD: distinct roles of APOC3 and PNPLA3 in a candidate gene studySemantic proximity Read